Our activities as a public equity investor are rooted in our history of private equity. That history has enabled us to apply the knowledge and expertise, built up over a period of 25 years, to the public equity field. We started our public equity journey in 2008 via a strategic partnership with APG, one of the world’s largest asset managers. They were interested in investing in the healthcare sector, however, they lacked the expertise required to build exposure. That's where we came in. Since then, our investment strategy has been proven to work. From 2008 to 2016, we have generated a total return in excess of +500% (+24.1% per annum). Subscribe here to receive our monthly reports and Market Comments via
This return, which is GIPS compliant and known as the LSP Growth Composite, includes both our activities for APG since 2008 and our activities for the LSP Life Sciences Fund. It represents the most accurate and longest-term measure of our performance as a public equity fund manager.
LSP Life Sciences Growth Performance Report
LSP LIFE SCIENCES FUND
In April 2011, we launched our LSP Life Sciences Fund on Euronext. This fund is open-ended and publicly listed. As such, it allows investors to buy shares of the fund at any time, via their (internet) broker. The fund’s Bloomberg ticker is LSP NA and its ISIN Code is NL0009756394.
LSP Life Sciences Fund per 28-04-2017 € 204,73
Inception date : 28-04-2011